Weird share price action... the more progress there is, the more the share price drops. Can't have been too many times this has happened with a biotech company. By the time we get a successful 16 000 mg dose the share price should be at zero. That is after my wife told me a company that has a product that can kill just about any bacteria would be worth billions!!! I'm considering buying more, but I'm a bit over-extended into this already.
I checked a while back the price of the antibiotic treatment against sepsis that RCE was comparing their rat tests with. It appeared to be around $3000 per treatment(USD). RCE 327 seemed to work better in rats(survival rate 100%) than the other antibiotic treatment. It means there should be some money to be made with a better product. The share price is just not reflecting this. I'm perplexed to say the least.
Ann: Phase I Clinical Trial R327 Advances to High Dose Cohort, page-7
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.9M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 47.5¢ | 46.0¢ | $77.35K | 164.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49974 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 37899 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RCE (ASX) Chart |